Heron (Shanghai), a subsidiary of Nanjing Heron Pharmaceutical Science and Technology Co., Ltd., is dedicated to production, sales, technical and regulatory affairs service of Apls excipients and FDFS globally.

Heron (Shanghai)'s primary business activities include:

China lmport, registration, market and sales of pharmaceutical excipients

China Import, registration and sales of APls, intermediates and FDFs

Globally registration, market and sales of own APls and FDFs

Offer other products of market unmet needs, such as COVlD-19 protective products

Founded in 2013, Heron Pharma is a pharmaceutical company adhering to an innovation-driven and product differentiation strategy. Lt possesses world-leading research and development technology for active vitamin D derivatives, NCEs and first generics. The bulk production of active vitamin D derivative drugs can be provided over the world, including Alfacalcidol, Calcipotriol, Calcifediol, Calcitriol, Eldecalcitol, Doxercalciferol, Maxacalcitol, Paricalcitol, Tacalcitol, etc.

Over the past decade, 8 FDFs have been successfully commercialized in China, including the first generics of Tacalcitol Ointment and Regadenoson Injection. And 2 products Calcitriol Soft Capsules and Ketorolac Tromethamine Injection have been involved in the centralized purchasing of the National Healthcare Security Bureau.